130 related articles for article (PubMed ID: 26321295)
1. The expression of MAGE-C1 and MAGE-C2 in breast cancer and their clinical significance.
Hou S; Sang M; Zhao L; Hou R; Shan B
Am J Surg; 2016 Jan; 211(1):142-51. PubMed ID: 26321295
[TBL] [Abstract][Full Text] [Related]
2. Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism.
Hou SY; Sang MX; Geng CZ; Liu WH; Lü WH; Xu YY; Shan BE
Arch Med Res; 2014 Jan; 45(1):44-51. PubMed ID: 24316396
[TBL] [Abstract][Full Text] [Related]
3. [Expression of melanoma-associated antigen-C2 in breast cancers and mechanism].
Li N; Hou R; Zhao LM; Gu G; Hou SY
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):821-826. PubMed ID: 34407585
[No Abstract] [Full Text] [Related]
4. Pilot Study on MAGE-C2 as a Potential Biomarker for Triple-Negative Breast Cancer.
Zhao Q; Xu WT; Shalieer T
Dis Markers; 2016; 2016():2325987. PubMed ID: 27843173
[No Abstract] [Full Text] [Related]
5. MAGE-D4B is a novel marker of poor prognosis and potential therapeutic target involved in breast cancer tumorigenesis.
Germano S; Kennedy S; Rani S; Gleeson G; Clynes M; Doolan P; McDonnell S; Hughes L; Crown J; O'Driscoll L
Int J Cancer; 2012 May; 130(9):1991-2002. PubMed ID: 21618523
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer.
Xu X; Tang X; Lu M; Tang Q; Zhang H; Zhu H; Xu N; Zhang D; Xiong L; Mao Y; Zhu J
Exp Mol Pathol; 2014 Dec; 97(3):579-84. PubMed ID: 25445503
[TBL] [Abstract][Full Text] [Related]
7. Expression of MAGE-A3/6 in primary breast cancer is associated with hormone receptor negative status, high histologic grade, and poor survival.
Ayyoub M; Scarlata CM; Hamaï A; Pignon P; Valmori D
J Immunother; 2014; 37(2):73-6. PubMed ID: 24509169
[TBL] [Abstract][Full Text] [Related]
8. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma.
Cuffel C; Rivals JP; Zaugg Y; Salvi S; Seelentag W; Speiser DE; Liénard D; Monnier P; Romero P; Bron L; Rimoldi D
Int J Cancer; 2011 Jun; 128(11):2625-34. PubMed ID: 20715104
[TBL] [Abstract][Full Text] [Related]
9. Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients.
Curioni-Fontecedro A; Nuber N; Mihic-Probst D; Seifert B; Soldini D; Dummer R; Knuth A; van den Broek M; Moch H
PLoS One; 2011; 6(6):e21418. PubMed ID: 21738656
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.
Pabst C; Zustin J; Jacobsen F; Luetkens T; Kröger N; Schilling G; Bokemeyer C; Sauter G; Atanackovic D; Marx A
Exp Mol Pathol; 2010 Oct; 89(2):175-81. PubMed ID: 20621094
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma.
Han L; Jiang B; Wu H; Zhang S; Lu X
Int J Clin Exp Pathol; 2014; 7(10):6734-42. PubMed ID: 25400753
[TBL] [Abstract][Full Text] [Related]
12. Expression of MAGE-A11 in breast cancer tissues and its effects on the proliferation of breast cancer cells.
Xia LP; Xu M; Chen Y; Shao WW
Mol Med Rep; 2013 Jan; 7(1):254-8. PubMed ID: 23064813
[TBL] [Abstract][Full Text] [Related]
13. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
[TBL] [Abstract][Full Text] [Related]
14. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
15. 5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications.
Coral S; Sigalotti L; Altomonte M; Engelsberg A; Colizzi F; Cattarossi I; Maraskovsky E; Jager E; Seliger B; Maio M
Clin Cancer Res; 2002 Aug; 8(8):2690-5. PubMed ID: 12171902
[TBL] [Abstract][Full Text] [Related]
16. MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors.
Grau E; Oltra S; Martínez F; Orellana C; Cañete A; Fernández JM; Hernández-Martí M; Castel V
J Cancer Res Clin Oncol; 2009 Apr; 135(4):523-31. PubMed ID: 18820946
[TBL] [Abstract][Full Text] [Related]
17. Expression of melanoma antigen-encoding genes (MAGE) by common primers for MAGE-A1 to -A6 in colorectal carcinomas among Koreans.
Park MS; Park JW; Jeon CH; Lee KD; Chang HK
J Korean Med Sci; 2002 Aug; 17(4):497-501. PubMed ID: 12172045
[TBL] [Abstract][Full Text] [Related]
18. Expressions of MAGE-A10 and MAGE-A11 in breast cancers and their prognostic significance: a retrospective clinical study.
Lian Y; Sang M; Ding C; Zhou X; Fan X; Xu Y; Lü W; Shan B
J Cancer Res Clin Oncol; 2012 Mar; 138(3):519-27. PubMed ID: 22198676
[TBL] [Abstract][Full Text] [Related]
19. High expression of cancer testis antigens MAGE-A, MAGE-C1/CT7, MAGE-C2/CT10, NY-ESO-1, and gage in advanced squamous cell carcinoma of the larynx.
Figueiredo DL; Mamede RC; Spagnoli GC; Silva WA; Zago M; Neder L; Jungbluth AA; Saggioro FP
Head Neck; 2011 May; 33(5):702-7. PubMed ID: 20886663
[TBL] [Abstract][Full Text] [Related]
20. MAGE-A expression, immune microenvironment, and prognosis in upper urinary tract carcinoma.
Makise N; Morikawa T; Nakagawa T; Ichimura T; Kawai T; Matsushita H; Kakimi K; Kume H; Homma Y; Fukayama M
Hum Pathol; 2016 Apr; 50():62-9. PubMed ID: 26997439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]